All Slides

Obstructive Sleep Apnea (OSA)

  • Definition: Obstructive sleep apnea is a specific type of breathing pattern disruption occurring during sleep. To be classified as such, the disruption must last for at least 1010 seconds and occur with a minimum frequency of 55 times within a single hour.

  • Pathophysiology:

    • During sleep, the tongue, soft palate, and various neck structures are displaced.

    • This displacement leads to the obstruction of the upper airway.

    • Notably, the neural control responsible for chest movement remains unimpaired during these episodes (Ignatavicius et al., 20212021).

  • Airway Comparison:

    • Normal Airway: The airway remains open, and air moves freely through the structures.

    • Obstructive Sleep Apnea: The airway is physically blocked, preventing the movement of air despite respiratory effort.

  • Risk Factors:

    • Obesity.

    • Recessed jaw.

    • Increased neck circumference.

    • Enlarged tonsils.

    • Smoking.

  • Assessment Features (Signs and Symptoms):

    • Poor sleep quality and waking up feeling fatigued.

    • Observed apnea and snoring.

    • Hypoxia.

    • Restlessness and diaphoresis (excessive sweating).

    • Tachycardia (increased heart rate) and Hypertension (high blood pressure).

    • Depression.

  • Interventions: Continuous Positive Airway Pressure (CPAP):

    • Provides noninvasive positive-pressure ventilation (NPPV).

    • Function: Delivers a set level of positive airway pressure continuously throughout every cycle of inhalation and exhalation.

    • Nursing Responsibilities: Educate the patient regarding therapy adherence and the specific protocols for cleaning the equipment.

  • Post-Operative Support and Nursing Safety Priority:

    • Critical Rescue: The patient must be assessed at least every 22 hours during the initial 2424 hours following surgery.

    • Signs of Airway Narrowing or Partial Obstruction: Nursing staff must monitor for an increase in respiratory effort, the presence of stridor, drooling, an inability to swallow oral secretions, a reduction in the size of the oropharynx, decreasing oxygen saturation, or a rising end-tidal carbon dioxide level.

    • Action: If any of these signs/symptoms occur, initiate the Rapid Response Team (RRT) immediately to prevent a partial obstruction from escalating into a complete obstruction.

Influenza and Pneumonia

  • Influenza (The Flu):

    • Description: A highly contagious, acute viral respiratory infection.

    • Clinical Presentation: Rapid onset of severe headache, muscle aches, fever, chills, fatigue, and weakness. Symptoms such as watery nasal discharge, sore throat, and cough may also occur.

    • Contagion Period: Patients are contagious 2424 hours before symptoms manifest and remain contagious for up to 55 days after symptoms begin.

    • Recovery: Fatigue may persist for 11 to 22 weeks after the primary symptoms of the flu subside.

    • Health Promotion: Teach thorough handwashing, cough and sneeze etiquette, and the importance of staying home from work or school. Ensure education on influenza vaccines.

    • Major Complication: Development of pneumonia.

  • Pneumonia:

    • Definition: The presence of excess fluid in the lungs resulting from an inflammatory process.

    • Triggers: Inflammation can be triggered by infectious organisms, the inhalation of irritants, or aspiration.

    • Classifications of Pneumonia:

      • Community-acquired pneumonia.

      • Hospital-acquired pneumonia.

      • Health care-acquired pneumonia.

      • Ventilator-associated pneumonia.

Interprofessional Collaborative Care for Pneumonia

  • Recognizing Cues (Assessment):

    • Physical Findings: Flushed cheeks, anxious appearance, chest pain or discomfort, headache, cough, crackles upon auscultation, tachycardia, dyspnea, tachypnea, and sputum production (which may be bloody).

    • Indicators of Distress: Use of accessory muscles for breathing and hypoxemia.

    • Laboratory Assessment: Gram stain, culture and sensitivity of sputum, Complete Blood Count (CBC), blood cultures, and Arterial Blood Gas (ABG) analysis.

    • Imaging: Chest x-ray typically reveals an area of increased density.

  • Invasive Diagnostic Assessments:

    • Endoscopic examinations, specifically Bronchoscopy.

    • Thoracentesis.

    • Lung biopsy.

  • Analysis: Cues and Hypotheses:

    • Decreased gas exchange related to decreased diffusion at the alveolar-capillary membrane.

    • Potential for airway obstruction due to fatigue, muscle weakness, and excessive pulmonary secretions.

    • Potential for sepsis because microorganisms are present in a highly vascular area, combined with decreased immunity.

  • Planning and Implementation:

    • Improving Gas Exchange: Oxygen therapy, use of incentive spirometry, and bronchial hygiene.

    • Preventive Measures: Focus on preventing airway obstruction, sepsis, and empyema.

  • Care Coordination and Transition:

    • Focus on home care management and self-management education.

    • Prevention through the immunization of appropriate persons.

Pleural Effusion

  • Definition: A complication, often starting from pneumonia, where the pleural space fills with fluid.

  • Alternative Causes: Heart failure and lung cancer.

  • Symptoms: Sharp chest pain that intensifies with deep breaths or coughing, fever, cough, chills, hiccups, rapid breathing, and shortness of breath (SOB).

  • Diagnostic Tools: Chest x-ray, chest CT scan, and thoracentesis.

  • Treatment Goals:

    • Removal of the fluid.

    • Prevention of fluid re-accumulation.

    • Determination and treatment of the underlying cause.

Coronavirus (Covid-19)

  • Description: A contagious respiratory viral infection.

  • Standard Manifestations: Fever, chills, cough, SOB, dyspnea, fatigue, muscle aches, loss of taste or smell, sore throat, nausea/vomiting (N/V), diarrhea, and abdominal pain.

  • Unique Manifestations: Conjunctivitis, venous thromboembolic disease, encephalopathy accompanied by agitated delirium, and red nodules appearing on distal digits (observed in young people).

  • Diagnostics and Promotion: Viral and antibody Covid tests; Health promotion via the Covid-1919 vaccine.

  • Indications for Emergency Intervention:

    • Trouble breathing.

    • Persistent pain or pressure in the chest.

    • New-onset confusion.

    • Inability to wake or stay awake.

    • Cyanosis of the lips or face.

Pulmonary Tuberculosis (TB)

  • Pathogen: Highly communicable infection caused by Mycobacterium tuberculosis.

  • Transmission: Occurs via aerosolization.

  • Epidemiology: There is an increased incidence of TB secondary to HIV infection.

  • Assessment (Recognizing Cues):

    • Progressive fatigue and lethargy.

    • Nausea, anorexia, and weight loss.

    • Irregular menses.

    • Low-grade fever and night sweats.

    • Cough featuring mucopurulent sputum and blood streaks.

  • Diagnostic Assessment:

    • Sputum Culture: Used to confirm the diagnosis.

    • Tuberculin (Mantoux) Test: PPD is administered intradermally in the forearm. An induration measure of 10 mm10\,mm or greater in diameter is considered a positive result for exposure.

    • Interpretation: A positive reaction indicates exposure to TB or dormant disease; it does not necessarily mean active disease is present.

    • Blood Analysis: QuantiFERON-TB Gold.

  • Analysis and Hypotheses:

    • Airway obstruction potential due to thick secretions and weak cough effort.

    • Potential for drug-resistant disease and infection spread if therapy adherence is inadequate.

    • Anxiety, weight loss (due to nausea from therapy), and fatigue.

  • Interventions (Planning and Action):

    • Airway Clearance: Activities to promote the clearing of secretions.

    • Combination Drug Therapy: Strict adherence is required for Isoniazid, Rifampin, Pyrazinamide, and Ethambutol.

    • Infectiousness: A negative sputum culture indicates the patient is no longer infectious.

    • Holistic Care: Nutrition improvement, anxiety management, and fatigue management.

Pneumothorax and Chest Tubes

  • Pneumothorax Physiology: Usually caused by blunt chest trauma, resulting in air entering the pleural space. This causes a loss of negative pressure in the chest cavity, a rise in chest pressure, and a reduction of vital capacity, leading to lung collapse.

  • Assessment Cues:

    • Reduced or absent breath sounds on the affected side upon auscultation.

    • Hyperresonance on percussion.

    • Prominence of the involved chest side with poor respiratory movement.

    • Mediastinal Shift: Tracheal deviation away from the midline toward the unaffected side.

  • Tension Pneumothorax Symptoms:

    • Extreme respiratory distress.

    • Distended neck veins.

    • Cyanosis.

    • Blood pressure instability.

  • Chest Tube Placement:

    • Vessels/structures involved: Visceral pleura, pleural space, parietal pleura, lung, rib cage, and diaphragm.

    • Air Drainage Tube: Typically placed higher to evacuate air.

    • Blood Drainage Tube: Typically placed lower to evacuate fluid/blood.

  • Chest Tube Drainage System (e.g., Pleur-evac):

    • Components include the suction control, water seal, and drainage collection chamber.

    • The collection chamber may measure volumes up to 2500 mL2500\,mL.

Acute Respiratory Failure (ARF) and Distress Syndrome (ARDS)

  • Acute Respiratory Failure (ARF):

    • Classification: By abnormal blood gas values.

    • Ventilatory Failure: A problem with oxygen intake (ventilation) or air movement. Blood flow is normal, but air movement is inadequate. Common in COPD, Asthma, and Pneumothorax.

    • Oxygenation Failure: Air moves in and out normally, but fails to oxygenate blood adequately. Air movement and O2O_2 intake are normal, but lung blood flow is decreased. Common in Pneumonia and Pulmonary Emboli.

  • Acute Respiratory Distress Syndrome (ARDS):

    • Cause: A systemic inflammatory response.

    • Key Signs: Hypoxemia that persists even when 100%100\% oxygen (O2O_2) is administered; decreased pulmonary compliance and dyspnea.

    • Associations: Severe Covid-1919 and burns.

    • Nursing Priority: Early recognition of patients at high risk for the syndrome.

Questions & Discussion

  • Question 1: The nurse recognizes that a client with sleep apnea may benefit from which intervention(s)? (Select all that apply.)

    • A) Weight loss

    • B) Nasal mask to deliver BiPAP

    • C) A change in sleeping position

    • D) Medication to increase daytime sleepiness

    • E) Position-fixing device that prevents tongue subluxation

  • Answer 1: ANS: A, B, C, E.

    • Rationale: Weight loss, BiPAP, position changes, and tongue-fixing devices are all viable interventions. Clients must work with providers to determine severity and specific needs. Medication to increase daytime sleepiness is the opposite of what is needed (the goal is to reduce daytime sleepiness caused by poor night sleep).

  • Question 2: The nurse understands that which of the following is the most common symptom of pneumonia in the older adult patient?

    • A) Fever

    • B) Cough

    • C) Confusion

    • D) Weakness

  • Answer 2: ANS: C.

    • Rationale: A decrease in oxygenation to the brain in older adults often manifests as confusion, which is more common than traditional symptoms like fever or cough.

Cardiac Inherent Rates and Electrophysiology

  • Inherent Rates of Cardiac Pacemakers:

    • Sinoatrial (SA) node: 60−100 bpm60-100\,\text{bpm}.

    • Atrioventricular (AV) node: 40−60 bpm40-60\,\text{bpm}.

    • Ventricles (Purkinje fibers): 20−40 bpm20-40\,\text{bpm}.

  • Structures Not Visible on ECG:

    • The ECG cannot directly show the electrical activity of the following five structures:

      1. SA node.

      2. AV node.

      3. Bundle of His.

      4. Bundle branches.

      5. Purkinje network.

Components of the Electrocardiogram (ECG)

  • ECG Waves and Complexes:

    • P wave: Represents Atrial depolarization.

    • QRS complex: Represents Ventricular depolarization.

      • Q wave: Initial downward deflection.

      • R wave: Initial upward deflection.

      • S wave: Downward deflection following the R wave.

    • T wave: Represents Ventricular repolarization.

    • U wave: Occasionally seen following the T wave.

  • Intervals and Segments:

    • PR interval: Measured from the beginning of the P wave to the beginning of the QRS complex. Normal range: 0.12−0.20 secs0.12-0.20\,\text{secs}.

    • QRS duration: Measured from the start to the end of the QRS complex. Normal: <0.12 secs<0.12\,\text{secs}.

    • ST segment: The flat line between the end of the QRS and the start of the T wave.

    • QT interval: Measured from the beginning of the QRS to the end of the T wave.

    • RR interval: The time between two consecutive R waves, used to determine heart rate and regularity.

  • Physiological Correlation:

    • Atrial systole: Generally corresponds with the period following the P wave.

    • Ventricular systole: Generally corresponds with the period from the QRS complex through the T wave.

    • Refractory Periods:

      • Absolute refractory period: Precise period when the cells cannot be stimulated to depolarize again.

      • Relative refractory period: Period followng the absolute refractory period where a stronger-than-normal stimulus may cause depolarization.

      • Supernormal period: A brief window during which even a weak stimulus could trigger a response.

ECG Metrics and Interpretation Process

  • Technical Specifications:

    • Standard paper speed: 25 mm/sec25\,\text{mm/sec}.

    • Standard Grid Scale: 1 small square = 0.04 sec0.04\,\text{sec} horizontally and 0.1 mV0.1\,\text{mV} vertically.

  • The 5-Step Rhythm Interpretation Process:

    1. Evaluate QRS complexes: Check if they are regularly spaced and if the shapes are uniform.

    2. Evaluate P waves: Check if they are upright, matching, "married to" (precede) every QRS, and regularly spaced.

    3. Determine the type of regularity or pattern: Assess the spacing of both QRS complexes and P waves.

    4. Determine the heart rate: Identify if the rate is fast or slow; typical range is 60−100 bpm60-100\,\text{bpm}.

    5. Determine Intervals:

      • PR interval: Normal is 0.12−0.20 secs0.12-0.20\,\text{secs}.

      • QRS interval: Normal is <0.12 secs<0.12\,\text{secs}.

Rhythms Originating in the Atria

  • General Characteristics:

    • Usually rapid rhythms that usurp the sinus node.

    • Occasionally slow.

    • Impulses can originate in one or more irritable foci.

    • Treatment aims to return to sinus rhythm or slow the heart rate to tolerable levels.

  • Premature Atrial Contraction (PAC):

    • Rate: Any.

    • Regularity: Regular but interrupted by premature beats; usually followed by a compensatory pause.

    • P waves: Shaped differently from sinus P waves.

    • Intervals: PR 0.12−0.20 secs0.12-0.20\,\text{secs}; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: Stimulants, hypoxia, heart disease.

    • Adverse effects: Can lead to other arrhythmias; may be a sign of early Heart Failure (HF).

    • Treatment: Digitalis, calcium channel blockers, beta blockers, oxygen; omit stimulants.

  • Atrial Flutter (A-flutter):

    • Rate: Atrial 250−350 bpm250-350\,\text{bpm}; Ventricular varies by conduction.

    • Regularity: Regular or irregular.

    • P waves: None; replaced by "flutter waves" (sawtooth pattern).

    • Intervals: PR Not applicable; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: Pulmonary embolus, valvular heart disease, lung disease, thyrotoxicosis.

    • Adverse effects: Decreased cardiac output.

    • Treatment: Digitalis, calcium channel blockers, beta blockers, adenosine, carotid sinus massage, cardioversion.

  • Atrial Fibrillation (A-fib):

    • Rate: Atrial 350−700 bpm350-700\,\text{bpm}; Ventricular varies.

    • Regularity: Irregularly irregular.

    • P waves: None; replaced by a wavy baseline.

    • Intervals: PR Not applicable; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: MI, lung disease, valvular heart disease, hyperthyroidism.

    • Adverse effects: Decreased cardiac output, blood clots causing stroke or pulmonary embolus.

    • Treatment Patterns:

      • Duration < 48 hours: Digitalis, calcium channel blockers, beta blockers, amiodarone, cardioversion.

      • Duration > 48 hours (Non-emergent): Anticoagulation for 2−3 weeks2-3\,\text{weeks}, then cardioversion.

      • Duration > 48 hours (Emergency): Heparin, transesophageal echocardiogram (TEE) to rule out atrial clots, then cardioversion.

  • Supraventricular Tachycardia (SVT):

    • Rate: 130 bpm130\,\text{bpm} or higher.

    • Regularity: Regular.

    • P waves: Not seen.

    • Intervals: PR Not measurable; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: Stimulants, hypoxia, heart disease.

    • Adverse effects: Decreased cardiac output.

    • Treatment: Adenosine, Digitalis, calcium channel blockers, beta blockers, oxygen, cardioversion if unstable.

Rhythms Originating in the Ventricles

  • General Characteristics:

    • Rate ranges from zero to >250 bpm>250\,\text{bpm}.

    • Considered the most lethal rhythms.

    • Impulse originates in irritable foci and travels slowly, cell by cell, through ventricular tissue.

  • Premature Ventricular Contractions (PVC):

    • Regularity: Regular but interrupted by the PVC; includes a complete compensatory pause.

    • P waves: Usually not seen.

    • QRS: Wide and bizarre; duration >0.12 secs>0.12\,\text{secs}. T wave is opposite the QRS deflection.

    • Classifications:

      • Unifocal: PVCs look the same (from one focus).

      • Multifocal: PVCs look different (from multiple foci).

      • Couplet: Two consecutive PVCs.

      • Bigeminy: Alternating sinus beat and PVC (N-V-N-V).

      • Trigeminy: Two sinus beats for every one PVC (N-N-V-N-N-V).

      • Run of VT: Five or more consecutive PVCs.

    • Cause: Heart disease, hypokalemia, hypoxia, hypomagnesemia, stimulants, caffeine, stress.

    • Treatment: Supplemental potassium, oxygen, amiodarone. Treat the cause.

  • Agonal Rhythm:

    • Rate: <20 bpm<20\,\text{bpm}.

    • Regularity: Irregular.

    • QRS: Wide and bizarre, widening further as death nears.

    • Adverse effects: Profound shock, unconsciousness, death; usually no pulse.

    • Treatment: Atropine, epinephrine, vasopressin, dopamine, oxygen, pacemaker, CPR.

  • Idioventricular Rhythm (IVR):

    • Rate: 20−40 bpm20-40\,\text{bpm}.

    • Regularity: Regular.

    • QRS: Wide and bizarre (>0.12 secs>0.12\,\text{secs}).

  • Ventricular Tachycardia (VT/V-tach):

    • Rate: >100 bpm>100\,\text{bpm}.

    • Regularity: Usually regular.

    • P waves: Usually none; dissociated if present.

    • Cause: Heart disease, hypoxia, hypokalemia, hypomagnesemia, stimulants.

    • Treatment (with Pulse): Amiodarone, lidocaine, potassium, oxygen, cardioversion.

    • Treatment (Pulseless): Defibrillation, potassium, oxygen, epinephrine, or vasopressin.

  • Torsades de Pointes:

    • Rate: >200 bpm>200\,\text{bpm}.

    • Regularity: Regular or irregular.

    • QRS: Wide and bizarre; "twisting about the points."

    • Cause: Antiarrhythmic medications, hypokalemia, hypoxia, hypomagnesemia.

    • Treatment: Supplemental magnesium, cardioversion, oxygen.

  • Ventricular Fibrillation (VF/V-fib):

    • Rate: Cannot be counted.

    • ECG Finding: None; wavy or spiked baseline with no QRS complexes.

    • Cause: MI, hypoxia, drowning, drug overdose, accidental electric shock, potassium imbalance.

    • Treatment: Defibrillation, amiodarone, lidocaine, procainamide, oxygen, CPR, epinephrine.

  • Asystole:

    • Rate: Zero.

    • Finding: Flat line (check more than one lead).

    • Treatment: CPR, epinephrine, dopamine, pacemaker, oxygen. Note: Do NOT defibrillate. Atropine is no longer indicated.

Atrioventricular (AV) Blocks

  • General Concepts:

    • The underlying rhythm is always sinus; P waves are sinus P waves.

    • Caused by partial or complete interruption in impulse transmission at the AV node or bundle branches.

  • Degrees of AV Block:

    1. First Degree: Delay in transmission. PR interval is prolonged (>0.20 secs>0.20\,\text{secs}). No dropped beats.

    2. Second Degree, Mobitz I (Wenckebach): Progressive lengthening of PR interval until a QRS is dropped. Regular Atrial rate, irregular Ventricular rate.

    3. Second Degree, Mobitz II: PR interval is constant for conducted beats, but some QRS complexes are dropped. Highly dangerous; can progress to third degree.

    4. Third Degree (Complete Heart Block): No impulses reach the ventricles. Atria and Ventricles beat independently (AV dissociation). PR varies, R-R is constant.

  • Treatment for AV Blocks:

    • First Degree: Remove the cause (e.g., digitalis toxicity).

    • Mobitz I: Observation; atropine if symptomatic.

    • Mobitz II & Third Degree: Pacemaker, atropine, epinephrine/dopamine infusions, oxygen.

Pacemakers and Pacing Modes

  • Definitions:

    • Pacemaker: Electronic device that sends electrical signals to cause heart depolarization.

    • Electrical Capture: Evidenced by a pacemaker spike followed by a P wave or QRS complex.

    • Mechanical Capture: Confirmed by palpating a pulse.

  • Pacing Systems:

    • Single-Chamber: Lead in either the right atrium (Atrial Pacing) or right ventricle (Ventricular Pacing).

    • Dual-Chamber: Leads in both the right atrium and right ventricle.

    • Lead Types: Transvenous, Epicardial (screw-in sensing leads), and Transcutaneous (external pads).

  • Pacemaker Settings and Codes (NBG Code):

    • First Letter (Chamber Paced): A=Atria, V=Ventricle, D=Dual.

    • Second Letter (Chamber Sensed): A, V, D, or O (none).

    • Third Letter (Response to Sensing): I=Inhibited, T=Triggered, D=Dual.

    • Examples: VVI (Ventricular demand), DDD (Fully automatic/Dual).

  • Pacemaker Troubleshooting:

    • Failure to Pace: Absence of spikes on ECG. Causes: Battery failure, lead fracture, electromagnetic interference.

    • Failure to Capture: Spike is present but no complex follows it. Causes: Lead displacement, output (mA) set too low, electrolyte imbalance.

    • Failure to Sense (Undersensing): Pacemaker fails to see the patient's own beats; spikes occur randomly (e.g., inside T waves). Solution: Increase sensitivity.

    • Failure to Sense (Oversensing): Pacemaker senses extraneous electrical signals and inhibited itself unnecessarily. Spikes occur slower than the preset rate.

  • Transcutaneous Pacing (TCP):

    • Used as a "bridge" for significant bradycardia unresponsive to atropine.

    • Limitations: Patient discomfort proportional to intensity; risk of tissue damage/burns.


Cardiac Inherent Rates and Electrophysiology
  • Inherent Rates of Cardiac Pacemakers:

    • Sinoatrial (SA) node: 60−100 bpm60-100\,\text{bpm}.

      • The primary pacemaker of the heart, responsible for initiating electrical impulses that set the heart rhythm. It is located in the right atrium and is influenced by the autonomic nervous system.

    • Atrioventricular (AV) node: 40−60 bpm40-60\,\text{bpm}.

      • Acts as a secondary pacemaker. It receives impulses from the SA node and provides a critical delay that allows the atria to contract and fill the ventricles with blood before ventricular contraction occurs.

    • Ventricles (Purkinje fibers): 20−40 bpm20-40\,\text{bpm}.

      • Serve as a tertiary pacemaker in emergencies when higher pacemaker function is impaired. The Purkinje fibers distribute the electrical impulse throughout the ventricles, ensuring coordinated contraction.

  • Structures Not Visible on ECG:

    • The ECG cannot directly show the electrical activity of the following five structures:

      1. SA node.

      2. AV node.

      3. Bundle of His.

      4. Bundle branches.

      5. Purkinje network.

    • Understanding these structures is crucial as their dysfunction can lead to arrhythmias, which are often evident in clinical settings through patient symptoms rather than direct ECG findings.

Components of the Electrocardiogram (ECG)
  • ECG Waves and Complexes:

    • P wave: Represents atrial depolarization, indicating atrial contraction. The shape of the P wave can provide insight into atrial health.

    • QRS complex: Represents ventricular depolarization, leading to ventricular contraction.

      • Q wave: Initial downward deflection of the QRS complex.

      • R wave: Initial upward deflection following the Q wave, typically the tallest point in the complex.

      • S wave: Downward deflection following the R wave, completing the QRS complex.

    • T wave: Represents ventricular repolarization, allowing the heart muscle to prepare for the next contraction. The T wave shape can indicate various conditions related to myocardial oxygenation or electrolyte imbalances.

    • U wave: Occasionally seen following the T wave; its significance is still debated but may be related to repolarization abnormalities.

  • Intervals and Segments:

    • PR interval: Measured from the beginning of the P wave to the beginning of the QRS complex. Normal range: 0.12−0.20 secs0.12-0.20\,\text{secs}. Prolonged intervals can indicate AV block.

    • QRS duration: Measured from the start to the end of the QRS complex. Normal: <0.12 secs<0.12\,\text{secs}. Prolonged duration can indicate bundle branch block or other ventricular conduction delays.

    • ST segment: The flat line between the end of the QRS and the start of the T wave, essential for diagnosing ischemia or infarction.

    • QT interval: Measured from the beginning of the QRS to the end of the T wave. The length can be affected by heart rate and electrolyte imbalances; prolonged QT can lead to dangerous arrhythmias.

    • RR interval: The time between two consecutive R waves, used to determine the heart rate and rhythm regularity.

  • Physiological Correlation:

    • Atrial systole: Generally corresponds to the period following the P wave. This period is crucial for optimal ventricular filling.

    • Ventricular systole: Generally corresponds with the period from the QRS complex through the T wave, correlating with the actual contraction period of the ventricles.

    • Refractory Periods

      • Absolute refractory period: Precise period during which the myocardial cells cannot be stimulated to depolarize again, preventing reexcitation and ensuring a proper cardiac cycle.

      • Relative refractory period: The phase following the absolute refractory period where a stronger-than-normal stimulus may still cause depolarization, critical for potentially dangerous arrhythmias.

      • Supernormal period: A brief window during which even a weak stimulus could trigger a response, highlighting the heart's susceptibility to arrhythmias during this phase.

ECG Metrics and Interpretation Process
  • Technical Specifications:

    • Standard paper speed: 25 mm/sec25\,\text{mm/sec}, essential for accurate timing analysis.

    • Standard Grid Scale: 1 small square = 0.04 sec0.04\,\text{sec} horizontally and 0.1 mV0.1\,\text{mV} vertically, providing a standard reference for calculations.

  • The 5-Step Rhythm Interpretation Process:

    1. Evaluate QRS complexes: Check if they are regularly spaced and if the shapes are uniform. Abnormal shapes or irregular spacing may indicate underlying pathology.

    2. Evaluate P waves: Check if they are upright, matching, "married to" (precede) every QRS, and regularly spaced. Abnormalities may suggest atrial enlargements.

    3. Determine the type of regularity or pattern: Assess the spacing of both QRS complexes and P waves for rhythm classification, critical for assessing arrhythmias.

    4. Determine the heart rate: A typical range is 60−100 bpm60-100\,\text{bpm}. Rates outside this range may indicate bradycardia or tachycardia, necessitating further evaluation.

    5. Determine Intervals:

      • PR interval: Normal is 0.12−0.20 secs0.12-0.20\,\text{secs}; prolonged intervals signal possible AV block.

      • QRS interval: Normal is <0.12 secs<0.12\,\text{secs}; prolonged intervals may indicate conduction delays.

Rhythms Originating in the Atria
  • General Characteristics:

    • Usually rapid rhythms that usurp the sinus node, potentially leading to decreased cardiac output.

    • Occasionally slow; it is crucial to assess the underlying cause, as varying heart rates affect treatment decisions.

    • Impulses can originate in one or more irritable foci, making several arrhythmias amenable to treatment with antiarrhythmic medications or cardio version.

    • Treatment aims to return to sinus rhythm or slow the heart rate to tolerable levels, balancing therapeutic efficacy and patient safety.

  • Premature Atrial Contraction (PAC):

    • Rate: Any.

    • Regularity: Regular but interrupted by premature beats; usually followed by a compensatory pause.

    • P waves: Shaped differently from sinus P waves, which can signify ectopic atrial activity.

    • Intervals: PR 0.12−0.20 secs0.12-0.20\,\text{secs}; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: Stimulants (e.g., caffeine), hypoxia, heart disease.

    • Adverse effects: Can lead to other arrhythmias; may be a sign of early Heart Failure (HF), warranting further investigation.

    • Treatment: Digitalis, calcium channel blockers, beta blockers, oxygen; omit stimulants to reduce future occurrences.

  • Atrial Flutter (A-flutter):

    • Rate: Atrial 250−350 bpm250-350\,\text{bpm}; Ventricular varies depending on conduction type.

    • Regularity: Regular or irregular; the rhythm regularly alternating may include a variable ventricular response.

    • P waves: None; replaced by "flutter waves" (sawtooth pattern), indicative of a rapid atrial circuit.

    • Intervals: PR Not applicable; QRS <0.12 secs<0.12\,\text{secs}; important to note as QRS duration may change with different conduction AV patterns.

    • Cause: Pulmonary embolus, valvular heart disease, lung disease, thyrotoxicosis; understanding these causes can direct acute management and long-term risk reduction strategies.

    • Adverse effects: Decreased cardiac output and potential thrombus formation leading to stroke.

    • Treatment: Digitalis, calcium channel blockers, beta blockers, adenosine, carotid sinus massage, and/or cardioversion, tailored to stability and response.

  • Atrial Fibrillation (A-fib):

    • Rate: Atrial 350−700 bpm350-700\,\text{bpm}; Ventricular varies unpredictably, leading to decreased cardiac efficiency.

    • Regularity: Irregularly irregular; identifying this pattern is crucial for diagnosis.

    • P waves: None; replaced by a wavy baseline, where varying cycles demonstrate fibrillatory activity.

    • Intervals: PR Not applicable; QRS <0.12 secs<0.12\,\text{secs}.

    • Cause: MI, lung disease, valvular heart disease, hyperthyroidism; awareness of these causes affects management protocols.

    • Adverse effects: Decreased cardiac output and increased risk for blood clots, potentially leading to stroke or pulmonary embolus.

    • Treatment Patterns:

      • Duration < 48 hours: Digitalis, calcium channel blockers, beta blockers, amiodarone, and consider urgent or deferred cardioversion.

      • Duration > 48 hours (Non-emergent): Anticoagulation for 2−3 weeks2-3\,\text{weeks} prior to cardioversion to minimize thromboembolic hazards.

      • Duration > 48 hours (Emergency): Heparin administration, transesophageal echocardiogram (TEE) to rule out atrial clots, then consider urgent cardioversion if appropriate.

  • Supraventricular Tachycardia (SVT):

    • Rate: 130 bpm130\,\text{bpm} or higher, characterized by rapid onset.

    • Regularity: Regular, with rapid heart rhythms that may suddenly start and stop.

    • P waves: Not seen due to rapid pacing; distinguishing SVT from other causative arrhythmias can be crucial.

    • Intervals: PR Not measurable; QRS <0.12 secs<0.12\,\text{secs}, indicating narrower complexes typically associated with re-entry circuits.

    • Cause: Stimulants, hypoxia, and heart disease; recognizing these can lead to quick diagnosis and management.

    • Adverse effects: Decreased cardiac output may occur, necessitating prompt treatment to stabilize the patient.

    • Treatment: Adenosine for acute episodes, Digitalis, calcium channel blockers, beta blockers, oxygen, and cardioversion if the patient is unstable; employing the appropriate techniques and identifying the patient's status is critical.

Rhythms Originating in the Ventricles
  • General Characteristics:

    • Rate ranges from zero to >250 bpm>250\,\text{bpm}; high rates can indicate emergent arrhythmias requiring quick assessment.

    • Considered the most lethal rhythms; immediate recognition and intervention are critical to save a life.

    • Impulse originates in irritable foci and travels slowly, cell by cell, through ventricular tissue; this conduction pattern contributes significantly to the risk of serious arrhythmias.

  • Premature Ventricular Contractions (PVC):

    • Regularity: Regular but interrupted by the PVC; capturing the PVC sequence is crucial to accurate ECG interpretation; may include a complete compensatory pause.

    • P waves: Usually not seen; assessing the absence of P waves indicates the ectopic origin of the impulse.

    • QRS: Wide and bizarre; duration >0.12 secs>0.12\,\text{secs}; T wave is usually opposite the QRS deflection, a hallmark of PVC morphology.

    • Classifications:

      • Unifocal: PVCs look the same (from one focus);

      • Multifocal: PVCs look different (from multiple foci); identification has implications for treatment.

      • Couplet: Two consecutive PVCs, often concerning for underlying disease.

      • Bigeminy: Alternating sinus beat and PVC (N-V-N-V), which can exacerbate symptoms such as dizziness or palpitations.

      • Trigeminy: Two sinus beats for every one PVC (N-N-V-N-N-V), a significant sign of cardiac irritability.

      • Run of VT: Five or more consecutive PVCs, with greater implications for stability and potential treatments.

    • Cause: Heart disease, hypokalemia, hypoxia, hypomagnesemia, stimulants, caffeine, stress; recognizing these causes helps guide clinical management.

    • Treatment: Supplemental potassium, oxygen, amiodarone; essential to address the underlying cause to reduce ongoing PVCs.

  • Agonal Rhythm:

    • Rate: <20 bpm<20\,\text{bpm}; extremely low and indicates life-threatening conditions.

    • Regularity: Irregular, highlighting significant hemodynamic instability.

    • QRS: Wide and bizarre, widening further as death nears; monitoring these changes is critical.

    • Adverse effects: Profound shock, unconsciousness, death; usually no pulse, requiring urgent intervention.

    • Treatment: Atropine, epinephrine, vasopressin, dopamine, oxygen, pacemaker, CPR; immediate life-support measures are necessary.

  • Idioventricular Rhythm (IVR):

    • Rate: 20−40 bpm20-40\,\text{bpm}; identifying this rhythm usually indicates a critical state.

    • Regularity: Regular; usually points toward severe myocardial compromise.

    • QRS: Wide and bizarre (>0.12 secs>0.12\,\text{secs}), differentiating it from other rhythms; monitoring and intervention are usually necessary to prevent deterioration.

  • Ventricular Tachycardia (VT/V-tach):

    • Rate: >100 bpm>100\,\text{bpm}; usually leading to hemodynamic compromise.

    • Regularity: Usually regular, but variability occurs based on underlying conditions.

    • P waves: Usually none; when present, atrial activity dissociates from ventricular activity, critical for accurate diagnosis.

    • Cause: Heart disease, hypoxia, hypokalemia, hypomagnesemia, stimulants; mitigation requires understanding these causes.

    • Treatment (with Pulse): Amiodarone, lidocaine, potassium, oxygen, and cardioversion are tailored based on patient stability; assessing rhythm stability is vital.

    • Treatment (Pulseless): Defibrillation, potassium, oxygen, epinephrine, or vasopressin; immediate reaction to pulseless VT is a critical intervention.

  • Torsades de Pointes:

    • Rate: >200 bpm>200\,\text{bpm}; identifying this dangerous rhythm is critical for timely intervention.

    • Regularity: Regular or irregular; prompt evaluation should focus on the underlying cause.

    • QRS: Wide and bizarre; the characteristic "twisting about the points" necessitates immediate action.

    • Cause: Antiarrhythmic medications, hypokalemia, hypoxia, hypomagnesemia; these causative factors direct the management approach.

    • Treatment: Supplemental magnesium, cardioversion, oxygen; managing electrolyte levels is essential during treatment.

  • Ventricular Fibrillation (VF/V-fib):

    • Rate: Cannot be counted; immediate recognition is important as this rhythm is life-threatening.

    • ECG Finding: None; wavy or spiked baseline with no identifiable QRS complexes signals the need for urgent electrical intervention.

    • Cause: MI, hypoxia, drowning, drug overdose, accidental electric shock, potassium imbalance; understanding these potential triggers can improve outcomes.

    • Treatment: Defibrillation, amiodarone, lidocaine, procainamide, oxygen, CPR, epinephrine; time-sensitive interventions are necessary to prevent mortality.

  • Asystole:

    • Rate: Zero; confirmed as a flat line on the ECG (check more than one lead to confirm).

    • Finding: Flat line; proper identification can determine prognosis and appropriate management.

    • Treatment: CPR, epinephrine, dopamine, pacemaker, oxygen; Note: Do NOT defibrillate as this will not restore a rhythm. Atropine is no longer indicated in asystole management.

Atrioventricular (AV) Blocks
  • General Concepts:

    • The underlying rhythm is always sinus; P waves are consistently sinus in origin.

    • AV blocks can result from structural or functional issues, impairing impulse transmission at the AV node or bundle branches; recognizing the type of block is key in patient management.

  • Degrees of AV Block:

    1. First Degree: Delay in transmission; PR interval is prolonged (>0.20 extsecs>0.20\, ext{secs}). No dropped beats; generally benign but may signal progressive pathology.

    2. Second Degree, Mobitz I (Wenckebach): Progressive lengthening of PR interval until a QRS is dropped; regular atrial rate, irregular ventricular rate detecting this pattern can guide management decisions.

    3. Second Degree, Mobitz II: Constant PR interval for conducted beats but some QRS complexes are dropped; considered highly dangerous as it can progress to third degree without warning.

    4. Third Degree (Complete Heart Block): No impulses reach the ventricles; atria and ventricles beat independently (AV dissociation), leading to severe bradycardia; immediate recognition is important.

  • Treatment for AV Blocks:

    • First Degree: Remove the cause (e.g., digitalis toxicity) to restore normal conduction.

    • Mobitz I: Observation might be sufficient; atropine can be considered if symptomatic.

    • Mobitz II & Third Degree: Pacemaker, atropine, epinephrine/dopamine infusions, and oxygen; these approaches share the goal of restoring adequate heart function.

Pacemakers and Pacing Modes
  • Definitions:

    • Pacemaker: Electronic device that sends electrical signals to induce heart depolarization, managing arrhythmias when the intrinsic conduction system fails.

    • Electrical Capture: Evidenced by a pacemaker spike followed by a P wave or QRS complex; confirms proper device functioning.

    • Mechanical Capture: Confirmed by palpating a pulse; this essential correlation ensures the pacemaker's efficacy.

  • Pacing Systems:

    • Single-Chamber: Lead in either the right atrium (Atrial Pacing) or right ventricle (Ventricular Pacing); these choices affect pacing strategy based on patient needs.

    • Dual-Chamber: Leads in both the right atrium and right ventricle; these systems allow for more physiologic pacing patterns.

    • Lead Types: Transvenous, Epicardial (screw-in sensing leads), and Transcutaneous (external pads); understanding these types aids in selecting appropriate intervention.

  • Pacemaker Settings and Codes (NBG Code):

    • First Letter (Chamber Paced): A=Atria, V=Ventricle, D=Dual, affecting therapeutic options available to the clinician.

    • Second Letter (Chamber Sensed): The ability to sense intrinsic beats (A, V, D, or O - none) impacts the pacing algorithm.

    • Third Letter (Response to Sensing): I=Inhibited, T=Triggered, D=Dual; understanding pacing response is vital for optimizing therapy.

    • Examples: VVI (Ventricular demand), DDD (Fully automatic/Dual); each code provides insight into device functionality and pacing strategy.

  • Pacemaker Troubleshooting:

    • Failure to Pace: Absence of spikes on ECG; identifying potential causes is essential for timely intervention (e.g., battery failure, lead fracture, electromagnetic interference).

    • Failure to Capture: Spike is present but no complex follows it, which can result from lead displacement or inadequate output settings; monitoring capture status is critical for patient safety.

    • Failure to Sense (Undersensing): Pacemaker fails to see the patient's own beats; spikes occur randomly (e.g., inside T waves); increasing sensitivity may solve this problem.

    • Failure to Sense (Oversensing): Pacemaker sensors are responding to extraneous signals unnecessarily; spikes occur slower than the preset rate, requiring adjustments to minimize inappropriate inhibition.

  • Transcutaneous Pacing (TCP):

    • Used as a "bridge" for significant bradycardia unresponsive to atropine; TCP can rapidly provide pacing support in acute scenarios.

    • Limitations: Patient discomfort proportional to intensity is common; risk of tissue damage/burns necessitates monitoring and care.

Fundamentals and Definitions of Perfusion

  • Definition of Perfusion: Refers to the flow of blood through arteries and capillaries, which delivers essential nutrients and oxygen to cells while removing waste products.

  • Central Perfusion:

    • Represents the force of blood movement generated by cardiac output.

    • It requires adequate cardiac function, sufficient blood pressure, and adequate blood volume.

    • Cardiac Output (CO): Defined as the volume of blood ejected by the heart (specifically the left ventricle) each minute.

  • Tissue or Local Perfusion:

    • Represents the volume of blood that flows to a specific target tissue.

    • It requires patent (open) vessels, adequate hydrostatic pressure, and capillary permeability.

Cardiac Anatomy and Blood Flow

  • Surface Anatomy - Anterior View:

    • Right Side: Superior vena cava, Right pulmonary artery, Right atrium, Tricuspid valve, Inferior vena cava, Right ventricle.

    • Left Side: Left pulmonary artery, Pulmonic valve location, Left atrium, Aortic valve location, Mitral valve location, Left ventricle.

  • Surface Anatomy - Posterior View: Identifies the locations of the Left pulmonary artery, Right pulmonary artery, Coronary sinus, and Right ventricle.

  • Blood Flow Path: Unoxygenated blood (represented by dark arrows) enters via the vena cavae, moves through the right heart to the lungs; oxygenated blood (represented by white arrows) returns from the lungs to the left heart and is pumped to the systemic circulation.

Physiological Variations and Impairments

  • Impaired Central Perfusion:

    • Occurs when cardiac output is inadequate to meet the body's needs.

    • Results in a systemic effect where oxygenated blood fails to reach body tissues efficiently.

    • Severe impairment is associated with shock.

    • If left untreated, it results in ischemia, cellular injury, and eventual cell death.

  • Impaired Tissue (Local) Perfusion:

    • Associated with loss of vessel patency, vessel permeability, or inadequate central perfusion.

    • Results in localized effects (impaired blood flow to a specific affected tissue).

    • Leads to ischemia and cell death if the correction is not made.

Arterial vs. Venous Insufficiency

  • Arterial Insufficiency / Peripheral Arterial Disease (PAD):

    • Pathophysiology: Narrowing of arteries caused by atherosclerosis (plaque buildup), commonly affecting the pelvis and legs.

    • Clinical Symptoms: Cramping, pain, tired legs, or hip muscles that worsen during walking or activity and subside with rest (intermittent claudication).

    • Ulcer/Lesion Characteristics:

      • Location: End of toes, top of feet (dorsum), or lateral ankle region (malleolus).

      • Appearance: Very little drainage, little tissue granulation (pale/light pink or necrotic/black).

      • Margins: Deep, "punched out" appearance with noticeable round margins.

  • Venous Insufficiency / Peripheral Venous Disease (PVD):

    • Pathophysiology: Inadequate return of venous blood from the legs back to the heart.

    • Clinical Symptoms: Legs feel tired, heavy, achy, or cramped; pain worsens when standing and improves with leg elevation and activity.

    • Ulcer/Lesion Characteristics:

      • Location: Medial parts of lower legs and the medial ankle region.

      • Appearance: Swollen with drainage; granulation is present (deep pink to red).

      • Margins: Shallow with irregular edges.

Risk Factors for Impaired Perfusion

  • Populations at Greatest Risk:

    • Older adults.

    • Low-income and low-educational level individuals.

    • Men.

    • African Americans.

    • Individuals with a significant family history.

  • Modifiable Risk Factors:

    • Smoking and nicotine use.

    • Physical inactivity and sedentary lifestyle.

    • Obesity.

    • Psychological factors and high stress levels.

    • Poor diet.

Clinical Noticing: Cues and Assessment

  • General Cues (Adults): Pain, syncope (fainting), dizziness, dyspnea (shortness of breath), edema, bleeding, bruising, and fatigue.

  • Cues in Infants: Poor feeding, poor weight gain, failure to thrive, and a dusky skin color.

  • Cues in Toddlers/Children: Squatting (often to relieve dyspnea), fatigue, and developmental delays (failure to reach milestones).

  • Physical Assessment Components:

    • Vital Signs: Blood pressure, heart rate, etc.

    • Inspection: Observing skin color, presence of edema, and hair loss on extremities.

    • Palpation: Checking for skin temperature and peripheral pulses.

    • Auscultation: Listening to heart sounds and murmurs.

  • Pulse Palpation Sites: Carotid, Brachial, Radial, Ulnar, Femoral, Popliteal, Posterior tibial, and Dorsalis pedis.

Diagnostics and Prevention

  • Common Diagnostic Tests:

    • Labs: Cardiac enzymes/markers (such as Troponin), serum lipids, complete blood count (CBC), blood coagulability, and bone marrow biopsy.

    • Cardiac Studies: Electrocardiogram (ECG), exercise or pharmacologic cardiac stress tests.

    • Radiography: Chest x-ray, ultrasound, arteriogram, and venogram.

  • Primary Prevention: Focuses on lifestyle changes including smoking/nicotine cessation, healthy diet, regular exercise, and weight control.

  • Secondary Prevention (Screening):

    • Blood Pressure Screening: Community programs and public education on risk factors.

    • Goal: Identify high-risk individuals and promote health-promoting behaviors.

Pharmacotherapy and Interventions

  • Common Perfusion Medications:

    • Vasodilators, Vasopressors, Diuretics, Antidysrhythmics, Cardioglycosides.

    • Anticoagulants, Antiplatelet agents, Thrombolytics, and Antilipidemics.

  • Surgical Procedures - Central Perfusion: Pacemaker insertion, electrical cardioversion, ablation therapy, intraaortic balloon pump, cardiac valve surgery, cardiac transplant, and percutaneous coronary intervention (PCI).

  • Surgical Procedures - Tissue Perfusion: Bypass and/or graft surgery, stent placement, angioplasty, and endarterectomy.

Hypertension (High Blood Pressure)

  • Definition: The force of blood against artery walls is consistently too high, forcing the heart to work harder.

  • AHA Blood Pressure Categories:

    • Normal: <120/80 mm Hg< 120/80\,mm\,Hg.

    • Elevated: 120−129 mm Hg120 - 129\,mm\,Hg systolic AND <80 mm Hg< 80\,mm\,Hg diastolic.

    • Stage 1 Hypertension: 130−139 mm Hg130 - 139\,mm\,Hg systolic OR 80−89 mm Hg80 - 89\,mm\,Hg diastolic.

    • Stage 2 Hypertension: ≥140 mm Hg\ge 140\,mm\,Hg systolic OR ≥90 mm Hg\ge 90\,mm\,Hg diastolic.

    • Severe Hypertension: ≥180 mm Hg\ge 180\,mm\,Hg systolic AND/OR ≥120 mm Hg\ge 120\,mm\,Hg diastolic.

    • Hypertensive Emergency: ≥180/120 mm Hg\ge 180/120\,mm\,Hg accompanied by symptoms like chest pain, shortness of breath, back pain, numbness, weakness, vision changes, or difficulty speaking.

  • Primary (Essential) Hypertension: No clear cause. Risk factors include old age, obesity, salt-heavy diet, and sedentary lifestyle. It is known as the "Silent Killer" because it usually has no symptoms.

  • Secondary Hypertension: Caused by an underlying condition such as atherosclerosis, low renal blood flow, sleep apnea, hyperthyroidism, traumatic brain injury (TBI), or diabetes.

  • Treatment Management: Dietary management, regular exercise (30 minutes30\,minutes daily as tolerated), stress management, tobacco avoidance, and antihypertensive meds (diuretics for volume control).

  • Duration of Therapy: Patients with essential hypertension require medication for the rest of their lives to maintain stable control.

Heart Failure (CHF)

  • Definition: "Pump failure"; the inability of the heart to work effectively as a pump.

  • Etiology: Systemic hypertension is the most common cause; one-third of MI patients develop HF; valvular dysfunction causes pressure/volume overload.

  • Left-Sided Heart Failure:

    • Causes: Hypertension, coronary artery disease (CAD), myocardial infarction (MI), and valvular disease.

    • Clinical Presentation: Weakness, fatigue, dizziness, acute confusion, breathlessness, oliguria, nocturia, hacking cough, frothy pink-tinged sputum, and lungs with crackles or wheezes.

  • Right-Sided Heart Failure:

    • Causes: Left ventricular failure, right ventricular MI, or pulmonary hypertension.

    • Pathophysiology: Right ventricle cannot empty; volume and pressure increase in the venous system.

    • Clinical Presentation: Jugular vein distention (JVD), increased abdominal girth, dependent edema (legs/ankles), hepatomegaly, ascites, and nocturia.

    • Monitoring: Weight is the most reliable indicator of fluid gain/loss.

  • Diagnostics:

    • BNP (B-type Natriuretic Peptide): Elevated (Normal range: 0−100 pg/mL0 - 100\,pg/mL).

    • Echocardiography: Considered the best diagnostic tool for heart failure.

  • Management:

    • Gas Exchange: High Fowler's position, monitor RR every 1−4 hours1 - 4\,hours, goal O2O_2 saturation ≥90%\ge 90\%.

    • Preload Reduction: Diuretics, venous vasodilators, nutrition therapy.

    • Afterload Reduction: ACE inhibitors, ARBs, Human BNP.

    • Contractility Enhancement: Digoxin (Cardioglycoside), Beta-blockers, Aldosterone antagonists.

    • Pulmonary Edema Warning Signs: Crackles at bases, dyspnea at rest, disorientation. Treatment includes rapid-acting diuretics, IV morphine, and Nitroglycerin.

Cardiac Conduction and ECG Interpretation

  • Conduction Path: SA node →\rightarrow AV node (delay) →\rightarrow Bundle of His →\rightarrow Right and Left Bundle Branches →\rightarrow Purkinje fibers.

  • ECG Waveforms:

    • P wave: Atrial depolarization; firing of the SA node. Should not exceed 33 small boxes (0.12 mV/3 mm0.12\,mV/3\,mm) in height; must be rounded and symmetrical.

    • PR Interval: Atrial depolarization and the delay in the AV node (BeginningofPtobeginningofQRSBeginning of P to beginning of QRS). Normal range: 0.12 s0.12\,s to 0.20 s0.20\,s.

    • QRS Complex: Ventricular depolarization. Normal duration: 0.06 s0.06\,s to 0.10 s0.10\,s. A width >0.12 s> 0.12\,s indicates a bundle branch block (BBB) or ventricular rhythm.

    • ST Segment: Early ventricular repolarization. Elevation indicates myocardial injury; depression indicates ischemia, digoxin use, or reciprocal changes.

    • T wave: Ventricular repolarization. Peaked T-waves indicate hyperkalemia; inversion indicates ischemia.

    • QT Interval: Total time for ventricular depolarization and repolarization (BeginningofQRStoendofTBeginning of QRS to end of T). Normal: 0.32 s0.32\,s to 0.50 s0.50\,s. Prolonged QT increases risk for lethal dysrhythmias (TorsadesdePointesTorsades de Pointes).

  • Analysis Steps: Determine rate, determine rhythm regularity, analyze P waves, measure PR interval, measure QRS duration.

Specific Dysrhythmias

  • Sinus Tachycardia: Rate 100−150 beats/min100 - 150\,beats/min. Treat the cause (fever, pain, anxiety, hyperthyroidism).

  • Sinus Bradycardia: Rate <60 beats/min< 60\,beats/min. Treat with Atropine or pacing if symptomatic.

  • Atrial Fibrillation (AFib):

    • Characteristics: Erratic impulse formation; no discernible P waves; "irregularly irregular" ventricular rate; loss of the "atrial kick."

    • Risks: High risk for systemic emboli and stroke.

    • Treatment: Anticoagulants (Warfarin, Pradaxa, Xarelto, Eliquis), rate control (Cardizem, Beta-blockers, Digoxin), and rhythm control (Amiodarone, Flecainide).

    • Non-surgical: Cardioversion, radiofrequency catheter ablation.

Myocardial Infarction (MI) and ACS

  • Acute Coronary Syndrome (ACS): Spectrum including unstable angina and acute MI.

  • Chronic Stable Angina: Ischemia limited in duration; does not cause permanent damage; relieved by rest/Nitroglycerin.

  • Unstable Angina: New onset or worsening angina; ST changes on ECG but normal Troponin/CK levels.

  • Myocardial Infarction Types:

    • NSTEMI: Non-ST elevation MI; subendocardial ischemia.

    • STEMI: ST-segment elevation MI; transmural ischemia; represents a surgical emergency.

  • Diagnostic Markers: Troponin T and Troponin I are the primary laboratory indicators of myocardial damage.

  • Acute Management: Pain management (Nitroglycerin, Morphine, Oxygen), Semi-Fowler's position, Percutaneous Coronary Intervention (PCI/Stents).

  • Complications: Cardiogenic shock (symptoms: cold/clammy skin, poor pulses, tachycardia, hypotension, decreased urine output).

Peripheral Arterial Disease (PAD) Specifics

  • The Six P's of Arterial Insufficiency: Pain, Pallor, Pulselessness, Paresthesia, Paralysis, Poikilothermia (coolness).

  • Assessment Cues: Intermittent claudication, hair loss, dry/scaly skin, thickened toenails, and "dependent rubor" (redness when legs hang down).

  • Testing: Ankle-brachial index (ABI) compares blood pressure in the ankle to blood pressure in the arm.

Questions & Discussion

  • Q: What instruction is included for a simvastatin prescription?

  • A: Liver enzyme levels should be monitored every few months. Common side effects include fatigue and myalgias.

  • Q: Which OTC medications should a patient on Furosemide and Clonidine avoid?

  • A: Decongestant cough preparations, as they can cause increased dizziness, confusion, and motor coordination impairment.

  • Q: What is the desired response for Propranolol in HTN treatment?

  • A: Decreased cardiac rate with a resulting decrease in cardiac output.

  • Q: A patient has a BP of 150/96 mm Hg150/96\,mm\,Hg, is 20 lb20\,lb overweight, and cholesterol is 240 mg/dL240\,mg/dL. What is the priority?

  • A: Refer to a doctor for follow-up and medications alongside lifestyle changes.


  • Definition of Perfusion: Refers to the flow of blood through arteries and capillaries, which is critical as it delivers essential nutrients and oxygen to cells, tissues, and organs, while also removing carbon dioxide and other metabolic waste products. Adequate perfusion is essential for maintaining cellular function and homeostasis throughout the body.

  • Central Perfusion:

    • Represents the force of blood movement generated by cardiac output, which is the amount of blood the heart pumps in one minute. Central perfusion is necessary for delivering blood to the body's vital organs, including the heart and brain.

    • It requires adequate cardiac function (the heart must be effective as a pump), sufficient blood pressure to propel blood through the vessels, and adequate blood volume to fill the circulatory system.

    • Cardiac Output (CO): Defined as the volume of blood ejected by the heart (specifically the left ventricle) each minute, usually expressed in liters per minute (L/min). It is calculated by multiplying heart rate (HR) by stroke volume (SV), which is the amount of blood pumped with each heartbeat.

  • Tissue or Local Perfusion:

    • Represents the volume of blood that flows to a specific target tissue, ensuring that cellular metabolism occurs effectively by transporting oxygen and nutrients directly to those cells.

    • It relies on patent (open) vessels, adequate hydrostatic pressure to facilitate blood flow, and capillary permeability for the exchange of nutrients and waste products between blood and tissues.

    • Poor local perfusion can lead to ischemia, which if severe and prolonged, can result in tissue necrosis or death.

Pleural Space and Pulmonary Vascular Conditions

  • Hemothorax

    • Definition: This condition occurs when blood accumulates within the pleural space, which is the area between the chest wall and the lungs.

    • Example: A significant chest injury that causes bleeding into the thoracic cavity can result in a hemothorax.

    • Clinical Relevance: Patients are typically managed through the use of chest drainage procedures to evacuate the blood and through volume replacement strategies to stabilize the circulatory system.

  • Pneumothorax

    • Definition: A condition characterized by the presence of air in the pleural space, which creates pressure that leads to the collapse of the lung.

    • Example: A traumatic pneumothorax often occurs following an injury such as a rib fracture.

    • Clinical Relevance: This medical emergency requires the insertion of a chest tube to remove the air and continuous monitoring to ensure lung re-expansion.

  • Pulmonary Embolism (PE)

    • Definition: A sudden blockage occurring in a pulmonary artery, usually caused by a blood clot that has traveled from another part of the body.

    • Example: A patient presenting with sudden dyspnea (shortness of breath) and sharp chest pain may be suffering from a PE.

    • Clinical Relevance: Immediate treatment requires the administration of anticoagulation medication and, in severe cases, thrombolysis to dissolve the clot.

Obstructive and Chronic Airway Disorders

  • Asthma

    • Definition: A chronic inflammatory disorder of the airways that results in reversible airflow obstruction and narrowing of the bronchial tubes.

    • Example: A patient experiencing an asthma attack will typically display symptoms such as wheezing and severe dyspnea.

    • Clinical Relevance: Treatment and long-term management focus on the use of bronchodilators to open the airways and corticosteroids to reduce inflammation.

  • COPD (Chronic Obstructive Pulmonary Disease)

    • Definition: A progressive lung disease characterized by long-term airflow limitation, primarily caused by the combination of chronic bronchitis and emphysema.

    • Example: A classic presentation involves a patient with a persistent chronic cough accompanied by heavy sputum production.

    • Clinical Relevance: Essential management steps include smoking cessation to slow disease progression and the use of inhaled bronchodilators to manage symptoms.

Breathing Assistance and Support Devices

  • BiPAP (Bilevel Positive Airway Pressure)

    • Definition: A non-invasive ventilation device that provides two distinct levels of air pressure: a higher pressure level during inhalation and a lower pressure level during exhalation.

    • Used In: Specifically utilized during COPD exacerbations.

    • Clinical Relevance: The device effectively supports ventilation and reduces the patient's work of breathing.

  • CPAP (Continuous Positive Airway Pressure)

    • Definition: A device that delivers a constant, steady level of positive air pressure to keep the patient's airways open.

    • Used In: Most commonly used for the treatment of obstructive sleep apnea.

    • Clinical Relevance: It functions to improve oxygenation and prevents the collapse of the airway during sleep cycles.

  • Mechanical Ventilation

    • Definition: The use of a specialized machine to either assist or entirely replace the patient's spontaneous breathing effort.

    • Example: An intubated patient residing in an Intensive Care Unit (ICU).

    • Clinical Relevance: Management necessitates vigilant monitoring for potential complications, specifically ventilator-associated pneumonia (VAP).

Respiratory Physiology and Gas Exchange

  • Gas Exchange

    • Definition: The biological process involving the transfer of oxygen and carbon dioxide between the alveoli in the lungs and the bloodstream.

    • Example: Normal oxygenation levels observed in healthy lungs.

    • Clinical Relevance: Any impairment in gas exchange can lead to serious physiological states including hypoxemia and hypercapnia.

  • Hypercapnia

    • Definition: A condition where there is an abnormally elevated level of carbon dioxide (CO2CO_2) in the blood.

    • Numerical Threshold: Measured as a partial pressure of carbon dioxide (PaCO2PaCO_2) greater than 45 mmHg45\,mmHg.

    • Clinical Relevance: Frequently occurs in patients with COPD; it is managed through various forms of ventilation support to clear excess CO2CO_2.

  • Hypoxemia

    • Definition: A state of low oxygen levels specifically within the arterial blood.

    • Numerical Threshold: Measured as a partial pressure of oxygen (PaO2PaO_2) less than 80 mmHg80\,mmHg.

    • Clinical Relevance: This condition requires the administration of supplemental oxygen and close clinical monitoring.

  • Oxygenation

    • Definition: The vital process of delivering oxygen from the lungs to the tissues of the body.

    • Example: An assessment result such as a pulse oximetry reading of 98%98\%.

    • Clinical Relevance: Oxygenation is essential for cellular metabolism; any impairment in this process requires immediate medical intervention.

Acid-Base Imbalances

  • Metabolic Acidosis

    • Definition: A condition where the pH of the blood decreases (becomes more acidic) due to an excess of acid in the body or a significant loss of bicarbonate.

    • Example: Commonly seen in patients suffering from diabetic ketoacidosis.

    • Clinical Relevance: Requires the identification and correction of the underlying cause, and may necessitate bicarbonate therapy to stabilize pH levels.

  • Metabolic Alkalosis

    • Definition: A condition where the pH of the blood increases (becomes more alkaline) due to an excess of bicarbonate or a loss of acid.

    • Example: This can occur as a result of prolonged vomiting.

    • Clinical Relevance: Managed by treating the root cause and restoring proper electrolyte balance.

  • Respiratory Acidosis

    • Definition: A condition caused by the retention of CO2CO_2, which leads to a decrease in blood pH.

    • Example: Often observed during a COPD exacerbation.

    • Clinical Relevance: Treatment involves providing ventilation and addressing the underlying cause of the carbon dioxide retention.

  • Respiratory Alkalosis

    • Definition: A condition caused by the excessive loss of CO2CO_2, typically through over-breathing, leading to an increase in blood pH.

    • Example: Hyperventilation during a severe anxiety attack.

    • Clinical Relevance: Management consists of slowing the patient's breathing rate and treating the source of the hyperventilation.

Infectious and Inflammatory Conditions

  • Pneumonia

    • Definition: An infection that causes the inflammation of the lung tissue.

    • Example: Community-acquired pneumonia is a frequent clinical presentation.

    • Clinical Relevance: Treatment necessitates the administration of antibiotics and comprehensive supportive care.

  • Rhinitis

    • Definition: Inflammation affecting the nasal mucosa.

    • Example: Allergic rhinitis, which typically causes nasal congestion.

    • Clinical Relevance: Managed through the use of antihistamines and the avoidance of known allergic triggers.

  • Sinusitis

    • Definition: Inflammation of the sinus cavities.

    • Example: An acute sinus infection resulting in significant facial pain.

    • Clinical Relevance: Requires antibiotics if the infection is determined to be bacterial, along with clinical measures for symptomatic relief.

  • Ventilator-Associated Pneumonia (VAP)

    • Definition: A specific type of pneumonia that develops in patients who are intubated and on mechanical ventilation.

    • Example: An ICU patient exhibiting fever and purulent (pus-like) secretions.

    • Clinical Relevance: Key prevention strategies include meticulous oral care and maintaining the elevation of the head of the bed (HOB).


Pleural Space and Pulmonary Vascular Conditions
  • Hemothorax

    • Definition: This condition occurs when blood accumulates within the pleural space, which is the area between the chest wall and the lungs. Hemothorax can arise from trauma or disease processes that cause bleeding into this space.

    • Example: A significant chest injury, such as from a motor vehicle accident or a stab wound, can cause bleeding into the thoracic cavity, leading to a hemothorax.

    • Clinical Relevance: Patients presenting with hemothorax may report symptoms such as chest pain, difficulty breathing, or hypotension. Management typically involves chest drainage procedures, often utilizing a chest tube to evacuate the blood, and volume replacement strategies to stabilize the circulatory system, along with monitoring vital signs and potential complications such as respiratory distress.

  • Pneumothorax

    • Definition: A condition characterized by the presence of air in the pleural space, which creates pressure that leads to the collapse of the lung. Pneumothorax can be classified as primary, secondary, or iatrogenic based on its cause.

    • Example: A traumatic pneumothorax often occurs following an injury such as a rib fracture or a penetrating injury to the chest wall.

    • Clinical Relevance: This medical emergency requires the insertion of a chest tube to remove the air and restore intrathoracic pressure, along with continuous monitoring to ensure lung re-expansion. Patients may exhibit symptoms of sudden chest pain, dyspnea, and decreased breath sounds on the affected side.

  • Pulmonary Embolism (PE)

    • Definition: A sudden blockage occurring in a pulmonary artery, usually caused by a blood clot that has traveled from another part of the body, commonly the legs (deep vein thrombosis). PE can lead to significant morbidity and mortality if not promptly managed.

    • Example: A patient presenting with sudden dyspnea (shortness of breath), sharp chest pain that may worsen with deep breaths, or excessive coughing (sometimes with blood) may be suffering from a PE.

    • Clinical Relevance: Immediate treatment requires the administration of anticoagulation medication to prevent further clotting and, in severe cases, thrombolysis to dissolve the clot. Risk factors for PE include prolonged immobility, recent surgeries, and certain hereditary conditions that increase clotting risk.

Obstructive and Chronic Airway Disorders
  • Asthma

    • Definition: A chronic inflammatory disorder of the airways that results in reversible airflow obstruction and narrowing of the bronchial tubes. Asthma can be triggered by allergens, irritants, stress, and weather conditions, varying in severity among patients.

    • Example: A patient experiencing an asthma attack will typically display symptoms such as wheezing, shortness of breath, chest tightness, and severe dyspnea. Symptoms can escalate quickly and may require urgent intervention.

    • Clinical Relevance: Treatment and long-term management focus on the use of bronchodilators to open the airways and inhaled corticosteroids to reduce inflammation. Asthma action plans are often developed for patients to manage their condition based on symptom severity and triggers.

  • COPD (Chronic Obstructive Pulmonary Disease)

    • Definition: A progressive lung disease characterized by long-term airflow limitation, primarily caused by the combination of chronic bronchitis and emphysema, typically resulting from long-term exposure to irritants such as tobacco smoke and air pollution.

    • Example: A classic presentation involves a patient with a persistent chronic cough accompanied by heavy sputum production, often worsening in the morning hours.

    • Clinical Relevance: Essential management steps include smoking cessation to slow disease progression, pulmonary rehabilitation to improve functional ability, and the use of inhaled bronchodilators and steroids to manage symptoms and reduce exacerbations.

Breathing Assistance and Support Devices
  • BiPAP (Bilevel Positive Airway Pressure)

    • Definition: A non-invasive ventilation device that provides two distinct levels of air pressure: a higher pressure level during inhalation and a lower pressure level during exhalation. The difference between the pressures makes it easier for patients to breathe.

    • Used In: Specifically utilized during COPD exacerbations and other conditions leading to respiratory failure.

    • Clinical Relevance: The device effectively supports ventilation and reduces the patient's work of breathing, improving oxygenation and carbon dioxide clearance. BiPAP is often indicated for patients who cannot tolerate invasive ventilation.

  • CPAP (Continuous Positive Airway Pressure)

    • Definition: A device that delivers a constant, steady level of positive air pressure to keep the patient's airways open.

    • Used In: Most commonly used for the treatment of obstructive sleep apnea, where it prevents airway collapse during sleep, facilitating uninterrupted breathing.

    • Clinical Relevance: It functions to improve oxygenation and prevent the collapse of the airway during sleep cycles; compliance with therapy is essential for effective management of sleep apnea.

  • Mechanical Ventilation

    • Definition: The use of a specialized machine to either assist or entirely replace the patient's spontaneous breathing effort. It is used when patients are unable to maintain adequate ventilation independently.

    • Example: An intubated patient residing in an Intensive Care Unit (ICU) may require mechanical ventilation due to severe respiratory distress or failure.

    • Clinical Relevance: Management necessitates vigilant monitoring for potential complications, specifically ventilator-associated pneumonia (VAP), as well as maintaining appropriate vent settings tailored to each patient's needs.

Respiratory Physiology and Gas Exchange
  • Gas Exchange

    • Definition: The biological process involving the transfer of oxygen and carbon dioxide between the alveoli in the lungs and the bloodstream, essential for maintaining aerobic metabolism in tissues.

    • Example: Normal oxygenation levels observed in healthy lungs can be assessed via pulse oximetry or arterial blood gases.

    • Clinical Relevance: Any impairment in gas exchange can lead to serious physiological states including hypoxemia (low blood oxygen) and hypercapnia (high carbon dioxide levels), requiring prompt medical intervention to restore normal respiratory function.

  • Hypercapnia

    • Definition: A condition where there is an abnormally elevated level of carbon dioxide (CO2CO_2) in the blood, often due to inadequate ventilation or a respiratory condition affecting gas exchange.

    • Numerical Threshold: Measured as a partial pressure of carbon dioxide (PaCO2PaCO_2) greater than 45 mmHg45 \text{ mmHg}.

    • Clinical Relevance: Frequently occurs in patients with COPD or asthma exacerbation; it is managed through various forms of ventilation support to clear excess CO2CO_2 and ensure proper oxygen delivery to tissues.

  • Hypoxemia

    • Definition: A state of low oxygen levels specifically within the arterial blood, which can lead to cardiovascular strain and organ dysfunction if severe.

    • Numerical Threshold: Measured as a partial pressure of oxygen (PaO2PaO_2) less than 80 mmHg80 \text{ mmHg}.

    • Clinical Relevance: This condition requires the administration of supplemental oxygen through a variety of delivery systems depending on the severity of the hypoxemia and close clinical monitoring to evaluate response.

  • Oxygenation

    • Definition: The vital process of delivering oxygen from the lungs to the tissues of the body, crucial for cellular metabolism.

    • Example: An assessment result such as a pulse oximetry reading of 98\text{\text{%}} indicates adequate oxygenation levels.

    • Clinical Relevance: Oxygenation is essential for maintaining normal physiological functions; any impairment in this process requires immediate medical intervention to prevent adverse outcomes.

Acid-Base Imbalances
  • Metabolic Acidosis

    • Definition: A condition where the pH of the blood decreases (becomes more acidic) due to an excess of acid in the body or a significant loss of bicarbonate.

    • Example: Commonly seen in patients suffering from diabetic ketoacidosis, renal failure, or lactic acidosis.

    • Clinical Relevance: Requires the identification and correction of the underlying cause, and may necessitate bicarbonate therapy to stabilize pH levels and restore normal biochemistry.

  • Metabolic Alkalosis

    • Definition: A condition where the pH of the blood increases (becomes more alkaline) due to an excess of bicarbonate or a loss of acid, which can disrupt normal cellular functions and gas exchange.

    • Example: This can occur as a result of prolonged vomiting, excessive diuretic use, or adrenal hyperfunction.

    • Clinical Relevance: Managed by treating the root cause and restoring proper electrolyte balance, often requiring potassium replacement and monitoring of electrolytes and renal function.

  • Respiratory Acidosis

    • Definition: A condition caused by the retention of CO2CO_2, which leads to a decrease in blood pH due to respiratory failure or obstruction affecting gas exchange.

    • Example: Often observed during a COPD exacerbation or in cases of severe asthma attacks.

    • Clinical Relevance: Treatment involves providing ventilation support and addressing the underlying cause of the carbon dioxide retention to restore adequate gas exchange and normalize arterial blood gases.

  • Respiratory Alkalosis

    • Definition: A condition caused by the excessive loss of CO2CO_2, typically through over-breathing (hyperventilation), leading to an increase in blood pH.

    • Example: Hyperventilation during a severe anxiety attack or panic attack can precipitate this condition.

    • Clinical Relevance: Management consists of slowing the patient's breathing rate through coaching and reassurance and treating the source of the hyperventilation to restore normal pH levels and physiological stability.

Infectious and Inflammatory Conditions
  • Pneumonia

    • Definition: An infection that causes the inflammation of the lung tissue, potentially impacting air exchange and leading to significant respiratory distress and hypoxemia. Various pathogens, including bacteria, viruses, and fungi, can be responsible for pneumonia.

    • Example: Community-acquired pneumonia is a frequent clinical presentation, often caused by Streptococcus pneumoniae, and typically treated with appropriate antibiotics.

    • Clinical Relevance: Treatment necessitates the administration of antibiotics, symptom management, and supportive care such as hydration and breathing treatments to facilitate recovery.

  • Rhinitis

    • Definition: Inflammation affecting the nasal mucosa, leading to symptoms such as nasal congestion, runny nose, sneezing, and itching.

    • Example: Allergic rhinitis often occurs seasonally as a reaction to environmental allergens such as pollen or indoor allergens like dust mites.

    • Clinical Relevance: Managed through the use of antihistamines, nasal corticosteroids, and the avoidance of known allergic triggers, with patient education on allergen exposure and symptom control strategies.

  • Sinusitis

    • Definition: Inflammation of the sinus cavities that can result in symptoms such as facial pain, headache, nasal congestion, and fever, indicating potential infection.

    • Example: An acute sinus infection (acute bacterial sinusitis) resulting in significant facial pain and purulent nasal discharge may necessitate medical evaluation and treatment.

    • Clinical Relevance: Requires antibiotics if the infection is determined to be bacterial, along with clinical measures for symptomatic relief, such as decongestants and saline nasal irrigation.

  • Ventilator-Associated Pneumonia (VAP)

    • Definition: A specific type of pneumonia that develops in patients who are intubated and on mechanical ventilation, typically occurring after 48 hours of intubation due to bacterial colonization of the oropharynx.

    • Example: An ICU patient exhibiting fever, purulent (pus-like) secretions, and deterioration in respiratory status is suggestive of VAP.

    • Clinical Relevance: Key prevention strategies include meticulous oral care, maintaining the elevation of the head of the bed (HOB), and regular assessment for extubation. Effective management requires broad-spectrum antibiotic therapy tailored to culture results and supportive care.

    • Angina Pectoris

      • Definition: Chest pain due to myocardial ischemia.

      • Example: Stable angina relieved by rest.

      • Clinical Relevance: Managed with nitrates and beta-blockers.

      Arrhythmia

      • Definition: Abnormal heart rhythm.

      • Example: Atrial fibrillation.

      • Clinical Relevance: Requires rate control and anticoagulation to prevent stroke.

      Central Perfusion

      • Definition: Blood flow from the heart to major organs.

      • Example: Normal cardiac output maintains organ function.

      • Clinical Relevance: Decreased central perfusion causes shock and organ failure.

      Deep Vein Thrombosis (DVT)

      • Definition: Blood clot in deep vein, usually in legs.

      • Example: Swelling and pain in calf.

      • Clinical Relevance: Risk of pulmonary embolism; requires anticoagulation.

      Heart Failure

      • Definition: Inability of heart to pump sufficient blood.

      • Example: Dyspnea and edema in CHF.

      • Clinical Relevance: Managed with diuretics, ACE inhibitors, and lifestyle changes.

      Hypertension

      • Definition: Persistent elevation of blood pressure above normal.

      • Example: Blood pressure of 150/95 mmHg150/95\,\text{mmHg}.

      • Clinical Relevance: Major risk factor for stroke, MI, and kidney disease.

      Left-Sided Heart Failure

      • Definition: Failure of left ventricle causing pulmonary congestion.

      • Example: Crackles and orthopnea.

      • Clinical Relevance: Requires diuretics and oxygen therapy.

      Myocardial Infarction (MI)

      • Definition: Death of heart muscle due to prolonged ischemia.

      • Example: Chest pain and elevated troponin.

      • Clinical Relevance: Requires immediate reperfusion therapy.

      Perfusion

      • Definition: Delivery of oxygen and nutrients to tissues via blood flow.

      • Example: Adequate perfusion in healthy tissues.

      • Clinical Relevance: Impaired perfusion leads to ischemia and organ damage.

      Peripheral Arterial Disease (PAD)

      • Definition: Narrowing of arteries reducing blood flow to limbs.

      • Example: Intermittent claudication in legs.

      • Clinical Relevance: Requires smoking cessation and antiplatelet therapy.

      Primary Hypertension

      • Definition: High BP without identifiable cause.

      • Example: Essential hypertension.

      • Clinical Relevance: Requires lifestyle changes and antihypertensive drugs.

      Right-Sided Heart Failure

      • Definition: Failure of right ventricle causing systemic congestion.

      • Example: Peripheral edema and ascites.

      • Clinical Relevance: Managed with fluid restriction and diuretics.

      Secondary Hypertension

      • Definition: High BP due to underlying condition.

      • Example: Renal artery stenosis causing hypertension.

      • Clinical Relevance: Treatment focuses on underlying cause.

      Tissue Perfusion

      • Definition: Blood flow through capillaries to tissues.

      • Example: Peripheral circulation to extremities.

      • Clinical Relevance: Poor tissue perfusion leads to ulcers and necrosis.

      Venous Insufficiency

      • Definition: Impaired venous return causing pooling of blood.

      • Example: Varicose veins and leg edema.

      • Clinical Relevance: Managed with compression therapy and elevation.


      • Definition: Angina pectoris is defined as chest pain or discomfort that arises when the heart muscle does not receive enough blood oxygen (myocardial ischemia). This can occur during physical exertion or emotional stress when the heart demands more oxygen than normal.

      • Types:

        • Stable Angina: Predictable chest pain that occurs with exertion or stress and is relieved by rest or medications (e.g., nitroglycerin).

        • Unstable Angina: Unexpected chest pain that occurs at rest or with minimal exertion, may last longer, and can indicate a heart attack.

        • Variant Angina: Caused by coronary artery spasm, usually occurs at rest and can be relieved by medication.

      • Symptoms: May include tightness, pressure, or aching sensation in the chest; pain that may radiate to the arms, neck, jaw, shoulder, or back; nausea; fatigue; shortness of breath; and sweating.

      • Example: For instance, a patient may experience stable angina when walking uphill, which is relieved by stopping to rest.

      • Risk Factors: Include coronary artery disease, high blood pressure, high cholesterol, smoking, diabetes, sedentary lifestyle, obesity, and family history of heart disease.

      • Clinical Relevance: Management typically involves a combination of lifestyle modifications (diet, exercise, and smoking cessation), medications such as nitrates for coronary vasodilation, beta-blockers for heart rate control, and antiplatelet agents like aspirin to prevent clot formation. In severe cases, revascularization procedures like angioplasty or coronary artery bypass grafting may be considered to improve blood supply to the heart muscle.